Form 4 Filing for ANAPTYSBIO, INC - Hughes Owen

This filing details a transaction by Hughes Owen, a director at ANAPTYSBIO, INC, on May 11, 2026. Owen acquired 11,250 Restricted Stock Units (RSUs) with a transaction value of $0.00 per share. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The vesting schedule indicates that 1/3 of the RSUs will vest on May 11, 2027, with the remaining vesting in equal annual installments over the following two years, contingent upon continued service. Following this transaction, Owen holds 11,250 shares of Common Stock underlying the RSUs.